Bethel 30 capsules — Class I drug recall D-921-2013
Terminated recall by Bethel Nutritional Consulting, Inc, reported 2013-09-04, distributed nationwide. Marketed Without An Approved NDA/ANDA: FDA analysis found this product contained undeclared sibutramine and ph
| Recall number | D-921-2013 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bethel Nutritional Consulting, Inc, New York, NY, United States |
| Recall initiated | 2013-06-11 |
| Classified | 2013-08-23 |
| Reported by FDA | 2013-09-04 |
| Terminated | 2018-06-27 |
| Distributed | Nationwide (US) |
| Quantity | 18,678 bottles |
| Reason classes | undeclared allergen, unapproved product |
| Lot numbers | 120514 |
| Expiration dates | 2014-12 |
Product
Bethel 30 capsules, packaged in 30 count bottles, Distributed by BETHEL INC. New York, New York
Reason for recall
Marketed Without An Approved NDA/ANDA: FDA analysis found this product contained undeclared sibutramine and phenolphthalein, two active ingredients that were once marketed in the U.S. but removed due to safety reasons, making this product an unapproved new drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-921-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.